One of Trump’s best sounding proposals to control drug pricing is a total dud
|07/11/2017||Posted by BusinessMediaguide.Com under General World News||
Last month we got a glimpse at what’s inside the Trump administration’s draft executive order to control drug pricing, and overall it was a pretty big win for drug companies.
They would be in line to get more power to charge monopoly prices overseas and be allowed to give even fewer discounts to hospitals with poor patients.
Plus, the administration is promising to roll back regulations that pharma has complained about.